StonvexLoading…
StonvexStonvexStonvexCore line items from ALLO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $0.00 | $22.00K | $95.00K | $74.00K |
Operating Income | $-209.31M | $-273.20M | $-327.74M | $-242.63M |
Net Income | $-190.89M | $-257.59M | $-327.26M | $-241.49M |
EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-1.58 |
Total Assets | $415.90M | $548.71M | $642.84M | $713.41M |
Total Liabilities | $123.36M | $126.53M | $130.60M | $132.78M |
Cash & Equivalents | $51.69M | $75.22M | $83.16M | $69.25M |
Free Cash Flow OCF − CapEx | $-149.63M | $-200.99M | $-239.25M | Not available |
Shares Outstanding | 229.41M | 212.21M | 168.64M | 168.18M |